BANK OF MONTREAL /CAN/ - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$12,687,000
+317075.0%
186,080
+193733.3%
0.01%
Q1 2021$4,000
-88.9%
96
-88.0%
0.00%
Q4 2020$36,000
-55.0%
803
-38.7%
0.00%
Q3 2020$80,000
+86.0%
1,310
+115.8%
0.00%
Q2 2020$43,000
+10.3%
607
-21.6%
0.00%
Q1 2020$39,000
-94.4%
774
-91.2%
0.00%
-100.0%
Q4 2019$695,000
+65.9%
8,747
+1.4%
0.00%
Q3 2019$419,000
+36.5%
8,630
+47.7%
0.00%
Q2 2019$307,000
+553.2%
5,841
+567.5%
0.00%
Q1 2019$47,000
-27.7%
875
-44.7%
0.00%
Q4 2018$65,000
+75.7%
1,582
+61.9%
0.00%
Q3 2018$37,000
-15.9%
977
-1.0%
0.00%
Q2 2018$44,000
+22.2%
987
+31.6%
0.00%
Q1 2018$36,000
-81.9%
750
-85.1%
0.00%
Q4 2017$199,000
-46.1%
5,050
-57.6%
0.00%
Q3 2017$369,000
-12.4%
11,900
-22.7%
0.00%
Q2 2017$421,000
-29.5%
15,400
-4.9%
0.00%
-100.0%
Q1 2017$597,000
+637.0%
16,200
+548.0%
0.00%
Q4 2015$81,000
-52.1%
2,500
-37.5%
0.00%
Q3 2015$169,0004,0000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders